Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SALIAI-UC1
- Development stage
- Unknown
- Lead developer
- Guangzhou Saliai Stem Cell Science and Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
SALIAI-UC1 is an investigational allogeneic cell therapy consisting of human umbilical cord-derived mesenchymal stem cells (UC-MSCs), developed by Guangzhou Sailera Stem Cell Technology for the treatment of knee osteoarthritis. The therapy is administered via intra-articular injection and works by leveraging the regenerative and immunomodulatory properties of MSCs. Once in the joint, these cells secrete a variety of paracrine factors, including anti-inflammatory cytokines and growth factors, which help to suppress synovial inflammation, inhibit the degradation of the extracellular matrix, and promote the repair of damaged cartilage. By modulating the local immune environment and stimulating endogenous repair processes, SALIAI-UC1 aims to alleviate pain and improve joint function in patients with degenerative knee conditions.
- Other names
- Human Umbilical Cord Mesenchymal Stem Cell InjectionSailera UC-MSC人脐带间充质干细胞注射液
Beyond the preview
Go deeper on SALIAI-UC1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SALIAI-UC1.